Last updated: 7 May 2024 at 5:10pm EST

Carolyn Tastad Net Worth




The estimated Net Worth of Carolyn M Tastad is at least $40.8 million dollars as of 1 March 2022. Ms. Tastad owns over 3,730 units of Procter & Gamble Co stock worth over $4,896,892 and over the last 11 years she sold PG stock worth over $29,067,132. In addition, she makes $6,851,060 as Group President - North America and Chief Sales Officer at Procter & Gamble Co.

Ms. Tastad PG stock SEC Form 4 insiders trading

Carolyn has made over 53 trades of the Procter & Gamble Co stock since 2014, according to the Form 4 filled with the SEC. Most recently she sold 3,730 units of PG stock worth $572,592 on 1 March 2022.

The largest trade she's ever made was exercising 51,867 units of Procter & Gamble Co stock on 27 October 2020 worth over $3,912,328. On average, Carolyn trades about 4,817 units every 31 days since 2014. As of 1 March 2022 she still owns at least 28,156 units of Procter & Gamble Co stock.

You can see the complete history of Ms. Tastad stock trades at the bottom of the page.





Carolyn Tastad biography

Carolyn M. Tastad is Group President - North America and Chief Sales Officer of the Company. Ms. Tastad began her P&G career in 1983. She has deep experience leading sales and market development organizations for P&G businesses in the U.S., Canada, Europe and globally, and has worked in a range of businesses including deep experience in Health and Beauty.

What is the salary of Carolyn Tastad?

As the Group President - North America and Chief Sales Officer of Procter & Gamble Co, the total compensation of Carolyn Tastad at Procter & Gamble Co is $6,851,060. There are 3 executives at Procter & Gamble Co getting paid more, with David Taylor having the highest compensation of $22,905,100.



How old is Carolyn Tastad?

Carolyn Tastad is 58, she's been the Group President - North America and Chief Sales Officer of Procter & Gamble Co since 2019. There are 16 older and 18 younger executives at Procter & Gamble Co. The oldest executive at Procter & Gamble Co. is Nelson Peltz, 78, who is the Independent Director.

What's Carolyn Tastad's mailing address?

Carolyn's mailing address filed with the SEC is 412 N. WELLS STREET, , CHICAGO, IL, 60654.

Insiders trading at Procter & Gamble Co

Over the last 19 years, insiders at Procter & Gamble Co have traded over $3,894,676,988 worth of Procter & Gamble Co stock and bought 6,769 units worth $466,837 . The most active insiders traders include Nelsontrian Fund Management..., Margaret C Whitman et Scott D Cook. On average, Procter & Gamble Co executives and independent directors trade stock every 5 days with the average trade being worth of $7,758,919. The most recent stock trade was executed by Jon R Moeller on 28 August 2024, trading 37,240 units of PG stock currently worth $6,289,464.



What does Procter & Gamble Co do?

The Procter & Gamble Company is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble.



What does Procter & Gamble Co's logo look like?

Procter & Gamble Co. logo

Complete history of Ms. Tastad stock trades at Kellanova Co et Procter & Gamble Co

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
1 Mar 2022 Carolyn M Tastad
CEO - Health Care
Vente 3,730 $153.51 $572,592
1 Mar 2022
28,156
6 Dec 2021 Carolyn M Tastad
CEO - Health Care
Exercice d'option 62 $150.61 $9,338
6 Dec 2021
31,992
17 Aug 2021 Carolyn M Tastad
CEO - Health Care
Vente 28,152 $144.11 $4,056,985
17 Aug 2021
28,497
2 Aug 2021 Carolyn M Tastad
CEO - Health Care
Vente 7,772 $141.77 $1,101,836
2 Aug 2021
28,332
26 May 2021 Carolyn M Tastad
CEO - Health Care
Vente 3,000 $138.20 $414,600
26 May 2021
36,104
11 May 2021 Carolyn M Tastad
CEO - Health Care
Vente 3,513 $137.27 $482,230
11 May 2021
38,935
26 Feb 2021 Carolyn M Tastad
CEO - Health Care
Vente 7,880 $125.77 $991,068
26 Feb 2021
42,448
15 Dec 2020 Carolyn M Tastad
CEO - Health Care
Exercice d'option 67 $137.61 $9,220
15 Dec 2020
50,501
27 Oct 2020 Carolyn M Tastad
CEO - Health Care
Exercice d'option 51,867 $75.43 $3,912,328
27 Oct 2020
81,330
18 Aug 2020 Carolyn M Tastad
CEO - Health Care
Vente 35,874 $136.25 $4,887,833
18 Aug 2020
47,990
31 Jul 2020 Carolyn M Tastad
CEO - Health Care
Vente 9,416 $130.00 $1,224,080
31 Jul 2020
47,824
27 Feb 2020 Carolyn M Tastad
CEO - Health Care
Vente 6,938 $115.82 $803,559
27 Feb 2020
53,421
28 Jan 2020 Carolyn M Tastad
CEO - Health Care
Exercice d'option 37,385 $78.74 $2,943,695
28 Jan 2020
89,430
20 Nov 2019 Carolyn M Tastad
CEO - Health Care
Exercice d'option 64 $121.95 $7,805
20 Nov 2019
60,589
26 Aug 2019 Carolyn M Tastad
CEO - Health Care
Vente 10,662 $118.00 $1,258,116
26 Aug 2019
61,225
20 Aug 2019 Carolyn M Tastad
CEO - Health Care
Vente 9,424 $119.80 $1,128,995
20 Aug 2019
71,887
22 May 2019 Carolyn M Tastad
CEO - Health Care
Exercice d'option 25,645 $68.09 $1,746,168
22 May 2019
86,686
1 May 2019 Carolyn M Tastad
CEO - Health Care
Vente 3,980 $105.85 $421,283
1 May 2019
60,840
28 Feb 2019 Carolyn M Tastad
CEO - Health Care
Vente 1,493 $98.57 $147,165
28 Feb 2019
53,302
28 Nov 2018 Carolyn M Tastad
CEO - Health Care
Exercice d'option 19,791 $63.12 $1,249,208
28 Nov 2018
68,560
20 Nov 2018 Carolyn M Tastad
CEO - Health Care
Exercice d'option 700 $63.28 $44,296
20 Nov 2018
55,372
15 Nov 2018 Carolyn M Tastad
CEO - Health Care
Vente 6,245 $92.94 $580,410
15 Nov 2018
54,756
14 Nov 2018 Carolyn M Tastad
CEO - Health Care
Exercice d'option 9,246 $60.38 $558,273
14 Nov 2018
67,001
22 Aug 2018 Carolyn M Tastad
CEO - Health Care
Vente 4,181 $83.52 $349,197
22 Aug 2018
61,001
6 Aug 2018 Carolyn M Tastad
CEO - Health Care
Exercice d'option 69 $81.41 $5,617
6 Aug 2018
54,678
1 Aug 2018 Carolyn M Tastad
CEO - Health Care
Vente 33,283 $80.67 $2,684,940
1 Aug 2018
54,609
15 Nov 2017 Carolyn M Tastad
CEO - Health Care
Vente 1,935 $78.93 $152,730
15 Nov 2017
59,744
30 Sep 2017 Carolyn M Tastad
CEO - Health Care
Vente 5,300 $89.18 $472,654
30 Sep 2017
57,191
15 Aug 2017 Carolyn M Tastad
CEO - Health Care
Vente 1,718 $92.04 $158,125
15 Aug 2017
62,401
15 Aug 2017 Carolyn M Tastad
CEO - Health Care
Vente 1,718 $92.04 $158,125
15 Aug 2017
62,401
7 Aug 2017 Carolyn M Tastad
CEO - Health Care
Exercice d'option 57 $91.29 $5,204
7 Aug 2017
59,319
7 Aug 2017 Carolyn M Tastad
CEO - Health Care
Exercice d'option 57 $91.29 $5,204
7 Aug 2017
59,319
15 Feb 2017 Carolyn M Tastad
CEO - Health Care
Vente 965 $91.20 $88,008
15 Feb 2017
55,515
15 Feb 2017 Carolyn M Tastad
CEO - Health Care
Vente 965 $91.20 $88,008
15 Feb 2017
55,515
2 Nov 2016 Carolyn M Tastad
CEO - Health Care
Vente 1,652 $86.90 $143,559
2 Nov 2016
61,940
2 Nov 2016 Carolyn M Tastad
CEO - Health Care
Vente 1,652 $86.90 $143,559
2 Nov 2016
61,940
30 Sep 2016 Carolyn M Tastad
CEO - Health Care
Vente 30,219 $88.00 $2,659,272
30 Sep 2016
56,419
30 Sep 2016 Carolyn M Tastad
CEO - Health Care
Vente 30,219 $88.00 $2,659,272
30 Sep 2016
56,419
16 Aug 2016 Carolyn M Tastad
CEO - Health Care
Vente 1,393 $86.30 $120,216
16 Aug 2016
63,592
27 May 2016 Carolyn M Tastad
CEO - Health Care
Vente 1,881 $81.40 $153,113
27 May 2016
62,294
29 Feb 2016 Carolyn M Tastad
CEO - Health Care
Vente 1,206 $80.47 $97,047
29 Feb 2016
47,340
8 Feb 2016 Carolyn M Tastad
CEO - Health Care
Exercice d'option 18,917 $63.49 $1,201,040
8 Feb 2016
67,398
1 Feb 2016 Carolyn M Tastad
CEO - Health Care
Exercice d'option 5,823 $57.48 $334,706
1 Feb 2016
2,830
1 Dec 2015 Carolyn M Tastad
CEO - Health Care
Vente 10 $75.28 $753
1 Dec 2015
1,993
30 Nov 2015 Carolyn M Tastad
CEO - Health Care
Exercice d'option 15 $34.57 $519
30 Nov 2015
2,018
6 Aug 2015 Carolyn M Tastad
CEO - Health Care
Exercice d'option 52 $75.62 $3,932
6 Aug 2015
48,393
20 May 2015 Carolyn M Tastad
CEO - Health Care
Vente 2,093 $80.62 $168,738
20 May 2015
48,341
26 Feb 2015 Carolyn M Tastad
CEO - Health Care
Vente 1,508 $85.25 $128,557
26 Feb 2015
36,979
6 Nov 2014 Carolyn M Tastad
CEO - Health Care
Vente 2,155 $88.86 $191,493
6 Nov 2014
38,372
29 Aug 2014 Carolyn M Tastad
CEO - Health Care
Exercice d'option 16,052 $59.11 $948,834
29 Aug 2014
2,761
7 Aug 2014 Carolyn M Tastad
CEO - Health Care
Exercice d'option 33 $80.60 $2,660
7 Aug 2014
42,332
1 May 2014 Carolyn M Tastad
CEO - Health Care
Vente 2,679 $82.31 $220,508
1 May 2014
42,239
27 Feb 2014 Carolyn M Tastad
CEO - Health Care
Vente 2,040 $77.70 $158,508
27 Feb 2014
39,070


Procter & Gamble Co executives and stock owners

Procter & Gamble Co executives and other stock owners filed with the SEC include: